(Q46102171)

21 February 2018

title

Antifracture efficacy and reduction of mortality in relation to timing of the first dose of zoledronic acid after hip fracture (English)

1 reference

21 February 2018

1 reference

5

Jay S Magaziner

1 reference

21 February 2018

author name string

Erik Fink Eriksen

1

1 reference

21 February 2018

Kenneth W Lyles

2

1 reference

21 February 2018

Cathleen S Colón-Emeric

3

1 reference

21 February 2018

Carl F Pieper

4

1 reference

21 February 2018

Jonathan D Adachi

6

1 reference

21 February 2018

Lars Hyldstrup

7

1 reference

21 February 2018

Chris Recknor

8

1 reference

21 February 2018

Lars Nordsletten

9

1 reference

21 February 2018

Catherine Lavecchia

10

1 reference

21 February 2018

Huilin Hu

11

1 reference

21 February 2018

Steven Boonen

12

1 reference

21 February 2018

Peter Mesenbrink

13

1 reference

21 February 2018

publication date

1 July 2009

1 reference

21 February 2018

Journal of Bone and Mineral Research

published in

1 reference

21 February 2018

volume

24

1 reference

21 February 2018

issue

7

1 reference

21 February 2018

page(s)

1308-1313

1 reference

21 February 2018

Zoledronic acid and clinical fractures and mortality after hip fracture

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5770985

Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5770985

Optimal timing of a single dose of zoledronic acid to increase strength in rat fracture repair.

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5770985

Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5770985

Adjusted mortality after hip fracture: From the cardiovascular health study

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5770985

Hip fracture mortality and morbidity--can we do better?

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5770985

Functional outcome and quality of life following hip fracture in elderly women: a prospective controlled study

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5770985

Risk of Mortality Following Clinical Fractures

1 December 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5770985

Early mortality after hip fracture: is delay before surgery important?

1 December 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19257818

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Massive intercalary bone allografts in the treatment of primary and secondary bone tumors. A report on 21 cases

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19257818

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1359/JBMR.090209

1 reference

21 February 2018

PMCID

5770985

1 reference

21 February 2018

PubMed ID

19257818

1 reference

21 February 2018